Chapter 1. Methodology and Scope
1.1. Market Segmentation & Scope
1.1.1. Application
1.1.2. Technology
1.1.3. Regional scope
1.1.4. Estimates and forecast timeline
1.2. Research Methodology
1.3. Information Procurement
1.3.1. Purchased database
1.3.2. GVR’s internal database
1.3.3. Secondary sources
1.3.4. Primary research
1.3.5. Details of primary research
1.3.5.1. Data for primary interviews in North America
1.3.5.2. Data for primary interviews in Europe
1.3.5.3. Data for primary interviews in Asia Pacific
1.3.5.4. Data for primary interviews in Latin America
1.3.5.5. Data for Primary interviews in MEA
1.4. Information or Data Analysis
1.4.1. Data analysis models
1.5. Market Formulation & Validation
1.6. Model Details
1.6.1. Commodity flow analysis (Model 1)
1.6.2. Approach 1: Commodity flow approach
1.6.3. Volume price analysis (Model 2)
1.6.4. Approach 2: Volume price analysis
1.7. List of Secondary Sources
1.8. List of Primary Sources
1.9. Objectives
1.9.1. Objective 1
1.9.2. Objective 2
Chapter 2. Executive Summary
2.1. Market Outlook
2.2. Segment Outlook
2.2.1. Application outlook
2.2.2. Technology outlook
2.2.3. Material outlook
2.2.4. Regional outlook
2.3. Competitive Insights
Chapter 3. Perfusion System Market Variables, Trends & Scope
3.1. Market Lineage Outlook
3.1.1. Parent market outlook
3.1.2. Related/ancillary market outlook
3.2. Penetration & Growth Prospect Mapping
3.3. Industry Value Chain Analysis
3.3.1. Reimbursement framework
3.4. Market Dynamics
3.4.1. Market driver analysis
3.4.1.1. Increasing prevalence of cardiovascular and respiratory diseases
3.4.1.2. Rising number of organ transplantations
3.4.1.3. Growth in Aging Population, Increasing Incidence of Multiple Organ Failures
3.4.1.4. Government and NGO Initiatives to Encourage Organ Donation
3.4.1.5. Increasing Investments in Cell - Based Research
3.4.1.6. Increase in Biologic Manufacturing
3.4.2. Market restraint analysis
3.4.2.1. High Cost of Organ Transplantation
3.4.2.2. Ethical Concerns and High Cost of Cell - Based Research
3.5. Perfusion System Market Analysis Tools
3.5.1. Industry Analysis - Porter’s
3.5.1.1. Supplier power
3.5.1.2. Buyer power
3.5.1.3. Substitution threat
3.5.1.4. Threat of new entrant
3.5.1.5. Competitive rivalry
3.5.2. PESTEL Analysis
3.5.2.1. Political landscape
3.5.2.2. Technological landscape
3.5.2.3. Economic landscape
3.5.3. Major Deals & Strategic Alliances Analysis
3.5.4. Market Entry Strategies
Chapter 4. Perfusion System: Application Estimates & Trend Analysis
4.1. Definitions and Scope
4.1.1. Cardiopulmonary Perfusion System
4.1.2. Cell Perfusion System
4.1.3. Ex - Vivo Organ Perfusion System
4.2. Product Market Share, 2021 & 2030
4.3. Segment Dashboard
4.4. Global Perfusion System Market by Application Outlook
4.5. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
4.5.1. Cardiopulmonary Perfusion System
4.5.1.1. Market estimates and forecast 2018 to 2030 (USD Million)
4.5.1.2. Oxygenators
4.5.1.2.1. Market estimates and forecast 2018 to 2030 (USD Million)
4.5.1.3. Heart - Lung Machine
4.5.1.3.1. Market estimates and forecast 2018 to 2030 (USD Million)
4.5.1.4. Perfusion Pumps
4.5.1.4.1. Market estimates and forecast 2018 to 2030 (USD Million)
4.5.1.5. Cannula
4.5.1.5.1. Market estimates and forecast 2018 to 2030 (USD Million)
4.5.1.6. Monitoring System
4.5.1.6.1. Market estimates and forecast 2018 to 2030 (USD Million)
4.5.1.7. Others
4.5.1.7.1. Market estimates and forecast 2018 to 2030 (USD Million)
4.5.2. Cell Perfusion System
4.5.2.1. Market estimates and forecast 2018 to 2030 (USD Million)
4.5.2.2. Bioreactor Perfusion System
4.5.2.2.1. Market estimates and forecast 2018 to 2030 (USD Million)
4.5.2.3. Microfluidic Perfusion System
4.5.2.3.1. Market estimates and forecast 2018 to 2030 (USD Million)
4.5.2.4. Gravity/Pressure - driven Perfusion System
4.5.2.4.1. Market estimates and forecast 2018 to 2030 (USD Million)
4.5.2.5. Small Mammal Organ Perfusion System
4.5.2.5.1. Market estimates and forecast 2018 to 2030 (USD Million)
4.5.3. Ex - vivo Perfusion System
4.5.3.1. Market estimates and forecast 2018 to 2030 (USD Million)
4.5.3.2. Hypothermic Perfusion System
4.5.3.2.1. Market estimates and forecast 2018 to 2030 (USD Million)
4.5.3.3. Normothermic Perfusion System
Chapter 5. Perfusion System Market: Regional Estimates & Trend Analysis
5.1. Regional market share analysis, 2022 & 2030
5.2. Regional Market Dashboard
5.3. Global Regional Market Snapshot
5.4. Regional Market Share and Leading Players, 2022
5.4.1. North America
5.4.2. Europe
5.4.3. Asia Pacific
5.4.4. Latin America
5.4.5. Middle East and Africa
5.5. SWOT Analysis, by Factor (Political & Legal, Economic and Technological)
5.5.1. North America
5.5.2. Europe
5.5.3. Asia Pacific
5.5.4. Latin America
5.5.5. Middle East and Africa
5.6. Market Size, & Forecasts, Volume and Trend Analysis, 2018 to 2030:
5.7. North America
5.7.1. Market estimates and forecast, 2018 - 2030 (Revenue, USD Million)
5.7.2. U.S.
5.7.2.1. Market estimates and forecast, 2018 - 2030 (Revenue, USD Million)
5.7.3. Canada
5.7.3.1. Market estimates and forecast, 2018 - 2030 (Revenue, USD Million)
5.8. Europe
5.8.1. U.K.
5.8.1.1. Market estimates and forecast, 2018 - 2030 (Revenue, USD Million)
5.8.2. Germany
5.8.2.1. Market estimates and forecast, 2018 - 2030 (Revenue, USD Million)
5.8.3. France
5.8.3.1. Market estimates and forecast, 2018 - 2030 (Revenue, USD Million)
5.8.4. Italy
5.8.4.1. Market estimates and forecast, 2018 - 2030 (Revenue, USD Million)
5.8.5. Spain
5.8.5.1. Market estimates and forecast, 2018 - 2030 (Revenue, USD Million)
5.8.6. Russia
5.8.6.1. Market estimates and forecast, 2018 - 2030 (Revenue, USD Million)
5.9. Asia Pacific
5.9.1. China
5.9.1.1. Market estimates and forecast, 2018 - 2030 (Revenue, USD Million)
5.9.2. Japan
5.9.2.1. Market estimates and forecast, 2018 - 2030 (Revenue, USD Million)
5.9.3. India
5.9.3.1. Market estimates and forecast, 2018 - 2030 (Revenue, USD Million)
5.9.4. Australia
5.9.4.1. Market estimates and forecast, 2018 - 2030 (Revenue, USD Million)
5.9.5. South Korea
5.9.5.1. Market estimates and forecast, 2018 - 2030 (Revenue, USD Million)
5.9.6. Singapore
5.9.6.1. Market estimates and forecast, 2018 - 2030 (Revenue, USD Million)
5.10. Latin America
5.10.1. Brazil
5.10.1.1. Market estimates and forecast, 2018 - 2030 (Revenue, USD Million)
5.10.2. Mexico
5.10.2.1. Market estimates and forecast, 2018 - 2030 (Revenue, USD Million)
5.10.3. Argentina
5.10.3.1. Market estimates and forecast, 2018 - 2030 (Revenue, USD Million)
5.11. MEA
5.11.1. Saudi Arabia
5.11.1.1. Market estimates and forecast, 2018 - 2030 (Revenue, USD Million)
5.11.2. South Africa
5.11.2.1. Market estimates and forecast, 2018 - 2030 (Revenue, USD Million)
5.11.3. UAE
5.11.3.1. Market estimates and forecast, 2018 - 2030 (Revenue, USD Million)
Chapter 6. Competitive Landscape
6.1. Recent Developments & Impact Analysis, By Key Market Participants
6.2. Company/Competition Categorization
6.2.1. Innovators
6.3. Vendor Landscape
6.3.1. List of key distributors and channel partners
6.3.2. Key customers
6.3.3. Key company market share analysis, 2022
6.3.4. Getinge AB
6.3.4.1. Company overview
6.3.4.2. Financial performance
6.3.4.3. Product benchmarking
6.3.4.4. Strategic initiatives
6.3.5. Medtronic, plc.
6.3.5.1. Company overview
6.3.5.2. Financial performance
6.3.5.3. Product benchmarking
6.3.5.4. Strategic initiatives
6.3.6. LivaNova,.
6.3.6.1. Company overview
6.3.6.2. Financial performance
6.3.6.3. Product benchmarking
6.3.6.4. Strategic initiatives
6.3.7. Terumo Corporation
6.3.7.1. Company overview
6.3.7.2. Financial performance
6.3.7.3. Product benchmarking
6.3.7.4. Strategic initiatives
6.3.8. Nipro Corporation
6.3.8.1. Company overview
6.3.8.2. Financial performance
6.3.8.3. Product benchmarking
6.3.8.4. Strategic initiatives
6.3.9. XENIOS AG
6.3.9.1. Company overview
6.3.9.2. Financial performance
6.3.9.3. Product benchmarking
6.3.9.4. Strategic initiatives
6.3.10. Repligen Corporation
6.3.10.1. Company overview
6.3.10.2. Financial performance
6.3.10.3. Product benchmarking
6.3.10.4. Strategic initiatives
6.3.11. Spectrum Laboratories, Inc.
6.3.11.1. Company overview
6.3.11.2. Financial performance
6.3.11.3. Product benchmarking
6.3.11.4. Strategic initiatives
6.3.12. Merck KGaA.
6.3.12.1. Company overview
6.3.12.2. Financial performance
6.3.12.3. Product benchmarking
6.3.12.4. Strategic initiatives
6.3.13. Harvard Bioscience, Inc.
6.3.13.1. Company overview
6.3.13.2. Financial performance
6.3.13.3. Product benchmarking
6.3.13.4. Strategic initiatives
6.3.14. ALA Scientific Instruments, Inc.
6.3.14.1. Company overview
6.3.14.2. Financial performance
6.3.14.3. Product benchmarking
6.3.14.4. Strategic initiatives
6.3.15. Lifeline Scientific, Inc.
6.3.15.1. Company overview
6.3.15.2. Financial performance
6.3.15.3. Product benchmarking
6.3.15.4. Strategic initiatives
6.3.16. XVIVO Perfusion AB
6.3.16.1. Company overview
6.3.16.2. Financial performance
6.3.16.3. Product benchmarking
6.3.16.4. Strategic initiatives
List of Tables
Table 1: List of Abbreviation
Table 2: North America perfusion system market, by application, 2018-2030 (USD Million)
Table 3: North America perfusion system market, by region, 2018-2030 (USD Million)
Table 4: U.S. perfusion system market, by application, 2018-2030 (USD Million)
Table 5: Canada perfusion system market, by application, 2018-2030 (USD Million)
Table 6: Europe perfusion system market, by application, 2018-2030 (USD Million)
Table 7: Europe perfusion system market, by region, 2018-2030 (USD Million)
Table 8: Germany perfusion system market, by application, 2018-2030 (USD Million)
Table 9: U.K. perfusion system market, by application, 2018-2030 (USD Million)
Table 10: France perfusion system market, by application, 2018-2030 (USD Million)
Table 11: Italy perfusion system market, by application, 2018-2030 (USD Million)
Table 12: Spain. perfusion system market, by application, 2018-2030 (USD Million)
Table 13: APAC. perfusion system market, by application, 2018-2030 (USD Million)
Table 14: APAC perfusion system market, by region, 2018-2030 (USD Million)
Table 15: China perfusion system market, by application, 2018-2030 (USD Million)
Table 16: Japan perfusion system market, by application, 2018-2030 (USD Million)
Table 17: India perfusion system market, by application, 2018-2030 (USD Million)
Table 18: Latin America. perfusion system market, by application, 2018-2030 (USD Million)
Table 19: Latin America perfusion system market, by region, 2018-2030 (USD Million)
Table 20: Brazil. perfusion system market, by application, 2018-2030 (USD Million)
Table 21: Mexico perfusion system market, by application, 2018-2030 (USD Million)
Table 22: Argentina. perfusion system market, by application, 2018-2030 (USD Million)
Table 23: Middle East and Africa. perfusion system market, by application, 2018-2030 (USD Million)
Table 24: Middle East and Africa perfusion system market, by region, 2018-2030 (USD Million)
Table 25: South Africa. perfusion system market, by application, 2018-2030 (USD Million)
Table 26: Saudi Arabia perfusion system market, by application, 2018-2030 (USD Million)
Table 27: UAE. perfusion system market, by application, 2018-2030 (USD Million)
List of Figures
Fig. 1: Market research process
Fig. 2: Data triangulation techniques
Fig. 3: Primary research pattern
Fig. 4: Primary interviews in North America
Fig. 5: Primary interviews in Europe
Fig. 6: Primary interviews in APAC
Fig. 7: Primary interviews in Latin America
Fig. 8: Primary interviews in MEA
Fig. 9: Market research approaches
Fig. 10: Value - chain - based sizing & forecasting
Fig. 11: QFD modeling for market share assessment
Fig. 12: Market formulation & validation
Fig. 13: Perfusion System: market outlook
Fig. 14: Perfusion System competitive insights
Fig. 15: Parent market outlook
Fig. 16: Related/ancillary market outlook
Fig. 17: Penetration and growth prospect mapping
Fig. 18: Industry value chain analysis
Fig. 19: Perfusion System market driver impact
Fig. 20: Perfusion System market restraint impact
Fig. 21: Perfusion System market strategic initiatives analysis
Fig. 22: Perfusion System market: application movement analysis
Fig. 23: Perfusion System market: application outlook and key takeaways
Fig. 24: Perfusion System market estimates and forecast, 2018-2030
Fig. 25: Cardiopulmonary Perfusion System market estimates and forecast, 2018-2030
Fig. 26: Oxygenators market estimates and forecast, 2018-2030
Fig. 27: Heart - Lung Machine market estimates and forecast, 2018-2030
Fig. 28: Perfusion Pumps market estimates and forecast, 2018-2030
Fig. 29: Cannula market estimates and forecast, 2018-2030
Fig. 30: Monitoring Systems market estimates and forecast, 2018-2030
Fig. 31: Others market estimates and forecast, 2018-2030
Fig. 32: Cell Perfusion System market estimates and forecast, 2018-2030
Fig. 33: Bioreactor Perfusion System market estimates and forecast, 2018-2030
Fig. 34: Microfluidic Perfusion System market estimates and forecast, 2018-2030
Fig. 35: Gravity/Pressure - driven Perfusion System market estimates and forecast, 2018-2030
Fig. 36: Small Mammal Organ Perfusion System market estimates and forecast, 2018-2030
Fig. 37: Ex - Vivo Organ Perfusion System market estimates and forecast, 2018-2030
Fig. 38: Hypothermic market estimates and forecast, 2018-2030
Fig. 39: Normothermic market estimates and forecast, 2018-2030
Fig. 40: Global Perfusion System market: regional movement analysis
Fig. 41: Global Perfusion System market: regional outlook and key takeaways
Fig. 42: Global market share and leading players
Fig. 43: North America market share and leading players
Fig. 44: Europe market share and leading players
Fig. 45: Asia Pacific market share and leading players
Fig. 46: Latin America market share and leading players
Fig. 47: Middle East & Africa market share and leading players
Fig. 48: North America: SWOT
Fig. 49: Europe SWOT
Fig. 50: Asia Pacific SWOT
Fig. 51: Latin America SWOT
Fig. 52: MEA SWOT
Fig. 53: North America, by country
Fig. 54: North America
Fig. 55: North America market estimates and forecast, 2018-2030
Fig. 56: U.S.
Fig. 57: U.S. market estimates and forecast, 2018-2030
Fig. 58: Canada
Fig. 59: Canada market estimates and forecast, 2018-2030
Fig. 60: Europe
Fig. 61: Europe. market estimates and forecast, 2018-2030
Fig. 62: U.K.
Fig. 63: U.K. market estimates and forecast, 2018-2030
Fig. 64: Germany
Fig. 65: Germany market estimates and forecast, 2018-2030
Fig. 66: France
Fig. 67: France market estimates and forecast, 2018-2030
Fig. 68: Italy
Fig. 69: Italy market estimates and forecast, 2018-2030
Fig. 70: Spain
Fig. 71: Spain market estimates and forecast, 2018-2030
Fig. 72: Russia
Fig. 73: Russia market estimates and forecast, 2018-2030
Fig. 74: Asia Pacific
Fig. 75: Asia Pacific market estimates and forecast, 2018-2030
Fig. 76: China
Fig. 77: China market estimates and forecast, 2018-2030
Fig. 78: Japan
Fig. 79: Japan market estimates and forecast, 2018-2030
Fig. 80: India
Fig. 81: India market estimates and forecast, 2018-2030
Fig. 82: Thailand
Fig. 83: Thailand market estimates and forecast, 2018-2030
Fig. 84: Australia
Fig. 85: Australia market estimates and forecast, 2018-2030
Fig. 86: Australia
Fig. 87: Singapore market estimates and forecast, 2018-2030
Fig. 88: Latin America
Fig. 89: Latin America market estimates and forecast, 2018-2030
Fig. 90: Brazil
Fig. 91: Brazil market estimates and forecast, 2018-2030
Fig. 92: Mexico
Fig. 93: Mexico market estimates and forecast, 2018-2030
Fig. 94: Argentina
Fig. 95: Argentina market estimates and forecast, 2018-2030
Fig. 96: Middle East and Africa
Fig. 97: Middle East and Africa. market estimates and forecast, 2018-2030
Fig. 98: Saudi Arabia
Fig. 99: Saudi Arabia market estimates and forecast, 2018-2030
Fig. 100: South Africa
Fig. 101: South Africa market estimates and forecast, 2018-2030
Fig. 102: UAE
Fig. 103: UAE market estimates and forecast, 2018-2030
Fig. 104: Participant categorization - Perfusion System market
Fig. 105: Market share of key market players - Perfusion System market
